Cargando…
Naltrexone/Bupropion extended release‐induced weight loss is independent of nausea in subjects without diabetes
Naltrexone/bupropion extended release (NB) is indicated as an adjunct to a reduced‐calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of ≥30 or ≥27 kg m(−2) and ≥1 weight‐related comorbidity (e.g. hypertension, type 2 diabetes and dys...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129540/ https://www.ncbi.nlm.nih.gov/pubmed/27477337 http://dx.doi.org/10.1111/cob.12157 |